2010

1) Béhier JM, Reynier JC, Bertoye PH, Vray M; participants of Round Table n°2 of Giens XXV.Clinical trials and E-health: impact of new information technology applied to clinical trials (including source data-medical records) and to human and drug research. Therapie. 2010 Jul-Aug;65(4):317-22, 309-15. Abstract

2) Breban R, Drake JM, Rohani P.A general multi-strain model with environmental transmission: invasion conditions for the disease-free and endemic states. J Theor Biol. 2010 Jun 7;264(3):729-36. Abstract

3) Delarocque-Astagneau E, Meffre C, Dubois F, Pioche C, Le Strat Y, Roudot-Thoraval F, Hillon P, Silvain C, Dhumeaux D, Desenclos JC; Hepatitis C Surveillance System Committee; Scientific Committee for the National Prevalence Survey of Hepatitis B and C Markers.The impact of the prevention programme of hepatitis C over more than a decade: the French experience. J Viral Hepat. 2010 Jun;17(6):435-43. Abstract

4) Garenne M.Urbanisation and child health in resource poor settings with special reference to under-five mortality in Africa. Arch Dis Child. 2010 Jun;95(6):464-8. Abstract

5) Germanaud D, Derache A, Traore M, Madec Y, Toure S, Dicko F, Coulibaly H, Traore M, Sylla M, Calvez V, Marcelin AG.Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. J Antimicrob Chemother. 2010 Jan;65(1):118-24. Abstract

6) Hohmann S, Garenne M.Health and wealth in Uzbekistan and sub-Saharan Africa in comparative perspective. Econ Hum Biol. 2010 Dec;8(3):346-60. Abstract

7) Hohmann S, Roche S, Garenne M.The changing sex ratios at birth during the civil war in Tajikistan: 1992-1997. J Biosoc Sci. 2010 Nov;42(6):773-86. Abstract

8) Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA.Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol. 2010 Jan;84(1):96-108. Abstract

9) Larsen C, Bousquet V, Delarocque-Astagneau E, Pioche C, Roudot-Thoraval F; HCV Surveillance Steering Committee; HCV Surveillance Group, Desenclos JC.Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France. J Med Virol. 2010 Oct;82(10):1647-54. Abstract

10) Mansour H, Laird ME, Saleh R, Casrouge A, Eldin NS, El Kafrawy S, Hamdy M, Decalf J, Rosenberg BR, Fontanet A, Abdel-Hamid M, Mohamed MK, Albert ML, Rafik M.Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype. J Infect Dis. 2010 Dec 1;202(11):1671-5. Abstract

11) Marion E, Eyangoh S, Yeramian E, Doannio J, Landier J, Aubry J, Fontanet A, Rogier C, Cassisa V, Cottin J, Marot A, Eveillard M, Kamdem Y, Legras P, Deshayes C, Saint-André JP, Marsollier L.Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis. 2010 Jul 6;4(7):e731. Abstract

12) Martin E, Moutailler S, Madec Y, Failloux AB.Differential responses of the mosquito Aedes albopictus from the Indian Ocean region to two chikungunya isolates. BMC Ecol. 2010 Mar 12;10:8. Abstract

13) Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, Warszawski J, Steinmetz J, Coste D, Meyer JF, Leiser S, Giordanella JP, Gueguen R, Desenclos JC.Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010 Apr;82(4):546-55. Abstract

14) Micol R, Tajahmady A, Lortholary O, Balkan S, Quillet C, Dousset JP, Chanroeun H, Madec Y, Fontanet A, Yazdanpanah Y.Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One. 2010 Nov 9;5(11):e13856. Abstract

15) Mostafa A, Mohamed MK, Saeed M, Hasan A, Fontanet A, Godsland I, Coady E, Esmat G, El-Hoseiny M, Abdul-Hamid M, Hughes A, Chaturvedi N.Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut. 2010 Aug;59(8):1135-40. Abstract

16) Mostafa A, Taylor SM, el-Daly M, el-Hoseiny M, Bakr I, Arafa N, Thiers V, Rimlinger F, Abdel-Hamid M, Fontanet A, Mohamed MK.Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010 Apr;30(4):560-6. Abstract

17) Mousson L, Martin E, Zouache K, Madec Y, Mavingui P, Failloux AB.Wolbachia modulates Chikungunya replication in Aedes albopictus. Mol Ecol. 2010 May;19(9):1953-64. Abstract

18) Moutailler S, Krida G, Madec Y, Bouloy M, Failloux AB.Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes. Vector Borne Zoonotic Dis. 2010 Oct;10(7):681-8. Abstract

19) Paez Jimenez A, Sharaf Eldin N, Rimlinger F, El-Daly M, El-Hariri H, El-Hoseiny M, Mohsen A, Mostafa A, Delarocque-Astagneau E, Abdel-Hamid M, Fontanet A, Mohamed MK, Thiers V. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut. 2010 Nov;59(11):1554-60. Abstract

20) Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, Dominguez S, Duval X, Gervais A, Ghosn J, Delarocque-Astagneau E, Pol S; Steering Committee of the HEPAIG Study.Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. Hepatology. 2010 Dec;52(6):1915-21. doi: 10.1002/hep.23959. Abstract

21) Rahelinirina S, Léon A, Harstskeerl RA, Sertour N, Ahmed A, Raharimanana C, Ferquel E, Garnier M, Chartier L, Duplantier JM, Rahalison L, Cornet M.First isolation and direct evidence for the existence of large small-mammal reservoirs of Leptospira sp. in Madagascar. PLoS One. 2010 Nov 24;5(11):e14111. Abstract

22) Schwarzinger M, Mohamed MK, Gad RR, Dewedar S, Fontanet A, Carrat F, Luchini S.Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo community. BMC Public Health. 2010 Dec 20;10:773. Abstract

23) Sire JM, Sow PS, Chartier L, Ndiaye B, Ndaye M, Sarr FD, Vray M, Boye CS, M'boup S, L'her P, Debonne JM, Mayaud C, Diop B.Aetiology of AFB negative pneumonias in hospitalized HIV patients in Dakar. Rev Mal Respir. 2010 Nov;27(9):1015-21. Abstract

24) Vardavas R, Breban R, Blower S.A universal long-term flu vaccine may not prevent severe epidemics. BMC Res Notes. 2010 Apr 5;3:92. Abstract

25) Wang W, Cavailler P, Ren P, Zhang J, Dong W, Yan H, Mardy S, Cailhol J, Buchy P, Sheng J, Fontanet A, Deubel V.Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai. J Clin Virol. 2010 Nov;49(3):211-8. Abstract  

T. Giles-Vernick et S. Craddock. Influenza and Public Health: Learning from Past Pandemics. London: Earthscan, 2010. Abstract

 

Mis à jour le 12/06/2014

Contact

Unité d'Epidémiologie des Maladies Emergentes


Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15


Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 7

Email: ueme@pasteur.fr

Où nous trouver ?

plan.jpg

Agenda

Tout l'agenda